2026–2029 Strategic Plan
The AACE Board of Directors has been hard at work shaping the future of our association. Through research, surveys, and in-depth interviews with members, Past Presidents, and key stakeholders, we identified the key goals and objectives of our 2026–2029 Strategic Plan.
LEARN MORE- Yes
Managing TED in Practice: Expanding the Endocrinologist’s Scope
CME: 1 | MOC: 1 | Nursing 1
Live 10/3/2025 at 1:00 PM EDT – 2:00 PM EDT
This complimentary live webinar is designed to help clinicians create a path to diagnosis when encountering a patient with thyroid eye disease.
- No
AACE Certificate: Dyslipidemia and Lipids Management
CME: 6 | MOC: 6 | Nursing 6
Starts 9/3/2025 | Expires 9/3/2027
This certificate program equips health care professionals with the knowledge to improve risk assessment, apply evidence-based therapies, and provide personalized treatment to optimize lipid management and enhance cardiovascular outcomes.
$295 | Informed Members - $235 | Engaged Members - $175 | Fellow Members $115
- No
AACE Annual Meeting 2025 On Demand
CME: 51.75 | MOC: 51.75 | Nursing 51.75
Starts 6/23/2025 | Expires 4/1/2026
Didn't make it to the AACE 2025 Annual Meeting? Access all the invaluable insights and groundbreaking discoveries with our on-demand session recordings.
$999 | Informed Member - $799 | Engaged Member - $599 | Fellow Member - $499
Together, We Are AACE
ABOUT
OUR MISSION
We are a global, inclusive community of endocrine-focused clinical members, affiliates and partners from every walk of professional life. We promote both formal and informal knowledge-sharing through our publications and education- and communication-focused programs. We pride ourselves in offering a uniquely personal experience that gives every member of our community a voice. Learn More
Our mission is elevating the practice of clinical endocrinology to improve global health.Learn More
We are the organization focused on endocrinology, diabetes, and metabolism that is most:
Recognized worldwide for its clinical leadership
Valued by clinical endocrinologists and other healthcare professionals
Trusted by patients
Respected by healthcare decision-makers and the public
AACE Statement on the FDA’s Actions to Address Unapproved Thyroid Medications
AACE, together with other leading professional medical societies and as recognized by the FDA, recommends levothyroxine as the primary treatment for hypothyroidism.
CEO September Highlights: Advancing Education and Collaboration
Read the latest blog by AACE CEO Johnnie White, MBA, CAE, CMP Fellow, featuring recent connections at ASAE, Best of AACE India, and the Midwest Endocrinology Organization, along with what’s ahead for September as we continue advancing education and collaboration in endocrine care.
August 2025 President’s Update: A Preview of AACE’s 2026–2029 Strategic Plan
AACE President Scott D. Isaacs, MD, FACP, FACE, shares highlights from the ORRSE 2025 Annual Meeting and offers a preview of AACE’s 2026–2029 Strategic Plan.
COMMUNITY
PERSPECTIVES
I am proud to be an AACE member and to witness the continued growth of this organization.
Dr. Matthew Levine
Read MoreOne of our great strengths is our diversity: our growing AACE community represents a huge wealth and resource of people of diverse backgrounds.
Dr. Leslie Eldeiry
Read MoreI am excited about our AACE and the place for clinical endocrinology in tomorrow’s health care ecosphere.
Dr. Sethu Reddy
Read More